Work

Reply to A. Azad et al

Year: 2013

Type: letter

Abstract: A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.51.4919

Authors: Matthew R. Cooperberg, Janet E. Cowan, Peter R. Carroll

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

Language: German

Topic: Galectins and Cancer Biology

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2055623823

Cites: 7

Cited by:

Related to: 10